Skip to main content
TipRanks
Go Ultimate75% OFF

Tianda Pharmaceuticals Ltd. (0455) Income Statement

0 Followers

Tianda Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2025), Tianda Pharmaceuticals Ltd.'s total revenue was HK$186.31M, a decrease of 38.61% from the same quarter last year. In Q4, Tianda Pharmaceuticals Ltd.'s net income was HK$-36.76M. See Tianda Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Mar 21
HK$ 322.94MHK$ 329.94MHK$ 532.09MHK$ 546.69MHK$ 509.96M
HK$ 133.31MHK$ 152.02MHK$ 255.53MHK$ 251.52MHK$ 241.22M
HK$ 187.40MHK$ 206.17MHK$ 284.56MHK$ 321.66MHK$ 283.25M
Depreciation and AmortizationHK$ 38.65MHK$ 38.23MHK$ 36.41MHK$ 50.25MHK$ 22.15M
HK$ -15.44MHK$ -15.92MHK$ 15.66MHK$ -19.89MHK$ -5.14M
HK$ -54.09MHK$ -54.15MHK$ -29.02MHK$ -70.14MHK$ -42.03M
HK$ -15.24MHK$ -191.00KHK$ 3.33MHK$ 6.29MHK$ 14.01M
HK$ -69.33MHK$ -54.34MHK$ -25.69MHK$ -63.85MHK$ -28.02M
HK$ -70.00MHK$ -61.37MHK$ -24.16MHK$ -54.64MHK$ -19.77M
Per Share Metrics
Basic EPSHK$ -0.03HK$ -0.03HK$ -0.01HK$ -0.03HK$ -0.01
Diluted EPSHK$ -0.03HK$ -0.03HK$ -0.01HK$ -0.03HK$ -0.01
Weighted Average Shares Outstanding2.15B2.15B2.15B2.15B2.15B
Weighted Average Shares Outstanding (Diluted)2.15B2.15B2.15B2.15B2.15B

Currency in HKD

Tianda Pharmaceuticals Ltd. Earnings and Revenue History

-300M0300M600M-24 %-12 %0 %12 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin